1. Home
  2. SYRA vs CHRO Comparison

SYRA vs CHRO Comparison

Compare SYRA & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRA
  • CHRO
  • Stock Information
  • Founded
  • SYRA 2020
  • CHRO 2002
  • Country
  • SYRA United States
  • CHRO United States
  • Employees
  • SYRA N/A
  • CHRO N/A
  • Industry
  • SYRA Other Specialty Stores
  • CHRO
  • Sector
  • SYRA Industrials
  • CHRO
  • Exchange
  • SYRA Nasdaq
  • CHRO Nasdaq
  • Market Cap
  • SYRA 4.2M
  • CHRO 3.9M
  • IPO Year
  • SYRA 2023
  • CHRO 2024
  • Fundamental
  • Price
  • SYRA $0.36
  • CHRO $0.66
  • Analyst Decision
  • SYRA
  • CHRO Strong Buy
  • Analyst Count
  • SYRA 0
  • CHRO 1
  • Target Price
  • SYRA N/A
  • CHRO N/A
  • AVG Volume (30 Days)
  • SYRA 178.3K
  • CHRO 100.6K
  • Earning Date
  • SYRA 10-29-2024
  • CHRO 11-13-2024
  • Dividend Yield
  • SYRA N/A
  • CHRO N/A
  • EPS Growth
  • SYRA N/A
  • CHRO N/A
  • EPS
  • SYRA N/A
  • CHRO N/A
  • Revenue
  • SYRA $7,741,558.00
  • CHRO N/A
  • Revenue This Year
  • SYRA $47.74
  • CHRO N/A
  • Revenue Next Year
  • SYRA N/A
  • CHRO N/A
  • P/E Ratio
  • SYRA N/A
  • CHRO N/A
  • Revenue Growth
  • SYRA 35.47
  • CHRO N/A
  • 52 Week Low
  • SYRA $0.34
  • CHRO $0.52
  • 52 Week High
  • SYRA $8.37
  • CHRO $6.00
  • Technical
  • Relative Strength Index (RSI)
  • SYRA 33.92
  • CHRO 48.22
  • Support Level
  • SYRA $0.37
  • CHRO $0.63
  • Resistance Level
  • SYRA $0.44
  • CHRO $0.69
  • Average True Range (ATR)
  • SYRA 0.04
  • CHRO 0.06
  • MACD
  • SYRA 0.00
  • CHRO 0.01
  • Stochastic Oscillator
  • SYRA 3.27
  • CHRO 52.55

About SYRA Syra Health Corp.

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.

About CHRO Chromocell Therapeutics Corporation

Chromocell Therapeutics Corp is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain and other associated medical conditions. The company's initial clinical focus is to selectively target the sodium ion-channel known as NaV1.7 for the treatment of various types of chronic neuropathic pain and eye pain. The Company's portfolio also includes pre-clinical work on other sodium channel receptor subtypes, and the company intends to explore these and other compounds for the treatment of additional pain indications.

Share on Social Networks: